HDACi have been shown to affect various cellular processes that are critical for cancer progression. These include cell cycle arrest, apoptosis, differentiation, and inhibition of angiogenesis. By altering the acetylation state of histones and other proteins, HDACi can modulate the expression of genes involved in these processes, thereby exerting anti-cancer effects.
